NCT00138242View on ClinicalTrials.gov

Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

October 31, 2006

Conditions

Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer

Interventions

DRUG

carboplatin

DRUG

docetaxel

PROCEDURE

adjuvant therapy

Trial Locations (1)

98111-0900

Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center, Seattle

All Listed Sponsors

lead

Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center

OTHER

NCT00138242 - Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer | Biotech Hunter | Biotech Hunter